A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
DUBLIN, Ireland, Feb. 08, 2024 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company"), today announces that management will present virtually at the Emerging Growth Conference on March 7, 2024. The Company invites individual and institutional investors as well as...
DUBLIN, Ireland, Feb. 07, 2024 -- Trinity Biotech Plc. (Nasdaq: TRIB) (the "Company") today announced that its New York based reference laboratory, Immco Diagnostics, has applied for a Proprietary Laboratory Analyses (PLA) code for its Early Sjögrens Syndrome...
-Investor call to be held today at 8:30 am ESTDUBLIN, Ireland, Jan. 31, 2024 -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company's results for the quarter ended September 30, 2023. Business Updates and Strategic Priorities In December 2023, the Company...
DUBLIN, Ireland, Jan. 31, 2024 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company") today announced that it has entered into a non-binding Letter of Intent with Bayer for the launch of a Continuous Glucose Monitoring ("CGM") biosensor device in China and India. This...
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million cash and 9 million ADSs -Strengthened investment relationship with...
Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ETDUBLIN, Ireland, Jan. 30, 2024 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company"), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory...
DUBLIN, Ireland, Dec. 27, 2023 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company"), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has begun commercial shipments to Kenya of its...
John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company"), a leading developer and manufacturer of diagnostic products for the point-of-care and...
DUBLIN, Ireland, Nov. 28, 2023 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company"), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on November 21, 2023 the Company received...
DUBLIN, Ireland, Oct. 10, 2023 -- Trinity Biotech plc (Nasdaq: TRIB) (the "Company"), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, welcomes the recent decision by the High Court of Kenya. The court...